Home | Publications | Country | Europe (East) | Hungary place holder
place holder place holder

Hungary

Smoking Cessation Aids in Hungary


Publication Date   April 2006
Publisher   Euromonitor International
Product Type   Report
Pages   31
ISBN Number   not applicable
Product Code   EUR302
Ask a question about this product?

Price £450.00

approximately: $841 | €571

Summary


The Smoking Cessation Aids in Hungary report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?
  • Get a detailed picture of the smoking cessation aids industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to developWith offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


Smoking Cessation Aids in Hungary

1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT

2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 1999-2004

3. OTC Healthcare Sales

3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
3.3 Competitive Environment
Table 5 OTC Healthcare Company Shares 2001-2004
Table 6 OTC Healthcare Brand Shares 2001-2004
3.4 Leading Company Profile: Egis Rt
Summary 1 Egis Rt: Operational Indicators 2005
3.5 Leading Company Profile: Richter Gedeon Rt
Summary 2 Richter Gedeon Rt: Operational Indicators 2004
3.6 Retail Distribution
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.7 Retailer Activity and Private Label Trends
Table 9 Penetration of Private Label by Sector 2001-2004
3.8 Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009

4. SMOKING CESSATION AIDS SALES

4.1 Number of Smokers
Table 12 Number of Smokers by Gender 1999-2004
4.2 Sector Performance
Table 13 Sales of Smoking Cessation Aids by Subsector: Value 1999-2004
Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 1999-2004
Table 15 Smoking Cessation Aids Company Shares 2001-2004
Table 16 Smoking Cessation Aids Brand Shares 2001-2004
Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
Summary 3 Smoking Cessation Aids: New Product Launches 2001-2003

5. OTHER OTC

6. DEFINITIONS